1. <dfn id="8ngdu"></dfn>

      1. <dfn id="8ngdu"></dfn>
        <rp id="8ngdu"><address id="8ngdu"></address></rp>
          <video id="8ngdu"><menu id="8ngdu"><kbd id="8ngdu"></kbd></menu></video>

          1. <b id="8ngdu"></b>

          Chemicals
          CIRS Group
          Chemicals
          Cosmetic
          Food
          Medical Devices
          Agrochemicals
          CIRS Testing
          Carbon Neutrality
          Search

          ECHA Releases 2025 Annual Statistics on Chemical Evaluations

          from CIRS by

          On February 27, 2026, the European Chemicals Agency (ECHA) published its annual evaluation statistics. The data shows that between 2009 and 2025, ECHA completed compliance checks for over 30% of chemical substances registered before 2019 with an annual tonnage exceeding 100 tons. This involved a cumulative review of 16,100 registration dossiers, covering 2,380 substances, which accounts for 23.5% of all submitted dossiers.

          Work Achievements in 2025

          I. Dossier Evaluation Progress

          1. Compliance Check Implementation

          Check Type

          Quantity

          Coverage

          Comprehensive Compliance Check

          190

          1,170+ dossiers, 179 substances

          Targeted Compliance Check

          24

          -

          Total

          214

          Nearly 1,200 dossiers, 196 substances

          Key inspection targets:

          • High-level hazard endpoints for high-tonnage substances.
          • Substances or groups of substances of potential concern.
          • Companies that left joint submissions and submitted individual dossiers (13 dossiers inspected, covering 11 substances, with almost all found non-compliant).

          2. Data Requirements and Focus Points 

          ECHA requested significant hazard data to clarify concerns regarding:

          • Human health hazards
          • Environmental hazards
          • Reproductive toxicity
          • Mutagenicity

          3. 2025 Dossier Evaluation Output

          Evaluation Type

          Quantity

          Coverage

          Comprehensive Compliance Checks (CCHs)

          190

          274 substances

          Testing Proposal Examinations (TPEs)

          108

          4. Decisions Adopted:

          • Decisions related to compliance checks: 208
          • Decisions on testing proposal examinations: 115
          • Total: 323 decisions

          II. Substance Evaluation Progress

          In 2025, ECHA made progress on 43 substances: the Evaluating Member States initiated evaluation on 10 new substances; ECHA adopted 12 substance evaluation decisions, requesting further information for 18 substances; and the Evaluating Member States completed the follow-up evaluation for 7 substances. Additionally, the evaluation was concluded (conclusion documents published) for 14 substances: among these, it was recommended to consider further risk management measures for 12 substances, while the necessary measures were already in place (or no measures were needed) for 2 substances.

          III. Further information requests & Follow-up

          Regarding the mechanism for requesting further information, ECHA completed the follow-up evaluation for 241 substances in 2025. Notably, approximately 70% of companies had submitted the requested supplementary information to the Agency; the remaining 30% of cases were referred to Member States for enforcement action. After receiving supplementary data from companies, ECHA referred over 15% of the cases to the competent authorities of the Member States, recommending consideration of further risk management measures.

          If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

          Further Information

          ECHA

            

          We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

          Contact Us
          +353 1 477 3710 (EU)
          +44 20 3239 9430 (UK)
          +1 703 520 1420 (USA)
          +86 571 8720 6574 (CN)
          +82 2 6347 8816 (KR)
          +81 070-9365-8022 (JP)
          1. <dfn id="8ngdu"></dfn>

            1. <dfn id="8ngdu"></dfn>
              <rp id="8ngdu"><address id="8ngdu"></address></rp>
                <video id="8ngdu"><menu id="8ngdu"><kbd id="8ngdu"></kbd></menu></video>

                1. <b id="8ngdu"></b>

                亚洲国产精品激情在线观看